LONDON (AFX) - Provexis PLC said it has entered into a long-term collaboration agreement with Unilever PLC to jointly develop a new concentrated format of its patented Fruitflow heart-health technology for application in Unilever's food product portfolio.

Financial details of the deal were not disclosed.

The partners plan to enter into a global licence arrangement for the technology.

Fruitflow is a patented natural extract from tomato which Provexis said has been shown in human trials to reduce the propensity for aberrant blood clotting that is typically associated with cardiovascular disease and which can lead to heart attack or stroke.

In 2005 the market for heart benefit foods was worth 4 bln usd globally, Provexis added.

Considering the growth potential this share has a target of about 8-10p in the medium tern and is a good buy at current levels

As usual, pls do ur own research.

agreed baler - think a lot of us had varying experiences with pxs - wasn't it sirocco I mean sirco lols - well yep but other big stuff going on apparently in the US?? - I had forgotten what blue looked like at pxs still can hardly believe it!

I think that Holland & Barrett still sell Sirco, in bottles. I had a quick look at Amazon and they have 4 cartons left! A company named Auravita states on their website that they are "out of stock until 25 November 2013"

Maybe there is going to be a relaunch with different packaging?

Chart looks more interesting these days!

Has now more than double during the last 2 weeks

the last placing / open offer was at 2.50p